“Most Effective Therapy to Date” – New Treatment Wipes Out Bladder Cancer in 82% of Patients #Science #HealthandMedicine #Oncology #BladderCancer #CancerTreatment #OncologyResearch

#ESMO25: Atezolizumab prolonged DFS in #ctDNA+ muscle-invasive #BladderCancer in the IMvigor011 #ClinicalTrial, providing first evidence in support of minimal residual disease-guided adjuvant #immunotherapy in this setting.
#ESMODailyReporter ➡️ https://ow.ly/ythW50XeYRP

#ESMO25: Peri-operative enfortumab vedotin plus pembrolizumab significantly prolonged event-free and overall survival in cisplatin-ineligible patients with muscle-invasive #BladderCancer in the phase III KEYNOTE-905/EV-303 trial
#ESMODailyReporter➡️httpsef="https://ow.ly/YVy550XeuKH" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky">https://ow.ly/YVy550XeuKH

Karima Oualla highlights that ctDNA is emerging as a highly prognostic tool in #BladderCancer and may help guide adjuvant therapy decisions. It’s a glimpse of precision oncology in action.

#ESMO25 #Oncology #OncSky #MedSky #MedEd

Join us as we bring you the real-time updates you need to know on optimising management of localised bladder cancer from #ESMO25. From new strategies and the latest trials to treatment pathways, stay tuned for LIVE expert insights

#Oncology #OncSky #MedSky #MedEd #BladderCancer

Oncology experts will be joining our friends and collaborators at COR2ED in Berlin for #ESMO25
Coming Soon👉 cor2ed.com/esmo-2025/up...

They will share their insights on the latest data on #BladderCancer #KidneyCancer #ProstateCancer #LungCancer #BreastCancer #GynOnc and Upper GI Cancers

Sign up

Check out the latest UroToday Beyond the Abstract paper, "Evaluating Surrogates for Overall Survival in the Adjuvant Treatment of #BladderCancer with #Chemotherapy," by our Clinical Director Dr. Cora N. Sternberg! #precisionmedicine

www.urotoday.com/recent-abstr...

Chemotherapy Approval Underlines Importance of Lymphocyte Monitoring in Bladder Cancer - Pat Soon-Shiong

oncodaily.com/voices/pat-s...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #BladderCancer

INLEXZO FDA Approval: A Game-Changer in Bladder Cancer Treatment

oncodaily.com/fda-approval...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #INLEXZO #FDAApproval #BladderCancer

Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI - Andrea Necchi

oncodaily.com/science/213051

#BladderCancer #Cancer #Chemotherapy #Immunotherapy #MRI #OncoDaily #Oncology #Radiology #Medicine #Health

Join the University of Birmingham Bladder Cancer Research Centre and the Kings College London & Guys Hospital Transforming cancer OUtcomes through Research (TOUR) team at the Edgbaston Park Hotel & Conference Centre on Friday 28th February 2025.

#bladdercancer #cancerresearch

Aetna denied my appeal. They say that catheterization is a surgical procedure, even though there is no doctor. This made my cancer treatment copay 10x higher! #aetna #insurance #bladdercancer #bcgtreatment www.tiktok.com/t/ZT2XtJxgb/

Watch Dr. Jen-Jane Liu discuss the management of muscle invasive #BladderCancer and outline emerging developments in perioperative systemic therapy in an interview with Urology Today.

#OHSUResearch: bit.ly/4kEdPRX

You can live a long, good quality of life with a urinary diversion! I'm 9 years out from my radical cystectomy and doing well. No evidence of disease since my procedure! #BladderCancer is consistently in the top 10 most common cancers according to @who.int. It is treatable & beatable!

Cystoscopy this week got me like 😬😬😬 #bladdercancer #bladdercancerwarrior #bladdercancerawareness #cancer

#bladdercancer #BladderCancerMonth25 #bladdercanceraware #GetChecked

Why does Gary Steinberg think "it's time for new and novel agents" when treating #NMIBC? Watch the full video over on Medthority for the latest updates from #ASCO25 on investigational treatments and clinical trial data #MedSky #MedEd #Oncology #BladderCancer

ow.ly/Ibr350WmlMs

Anna, a researcher at King’s College London, is looking for:
Bladder cancer patients (NMIBC or MIBC)
Health care professionals who see patients with suspected or diagnosed bladder cancer
to take part in a one-off online interview.

#BladderCancer #Research #CancerDiagnosis #PatientVoices

345 patients with #BladderCancer were randomised to receive standard whole bladder #radiotherapy (WBRT), adaptive tumour-focused radiotherapy (SART), or DART, which includes a boost to the tumour.

#BladderCancer symptoms can be mistaken for UTIs, especially in women. If your GP diagnoses a UTI after spotting blood in your urine, ask if the urine test confirmed an infection or if more tests are needed to rule out bladder cancer.

actionbladdercanceruk.org/about-bladde...

#BCAM2025 #ABCUK

TAR-200 Yields Prolonged DFS in BCG-Unresponsive, Papillary High-Risk NMIBC
#AUA25 #BladderCancer
www.onclive.com/view/tar-200...

Hacker News discussed TAR-200, a new treatment for high-risk non-muscle-invasive bladder cancer (NMIBC). The thread covered its mechanism, promising Phase 2 trial results, and the implications of bladder cancer's high recurrence rate, alongside patient experiences. #BladderCancer 1/5

Slow–release chemo shows promise for bladder cancer TAR-200, a device that delivers gemcitabine over 3 weeks, eliminated tumors in 80% of patients in a new study.
#TCSC #CancerResearch #BladderCancer #Oncology

www.oncology-central.com/slow-release...

We’re thrilled to be an official charity partner for the London Landmarks Half Marathon 2026!

Join us on Sunday 12th April 2026.

Sign up for one of our charity places today: events@actionbladdercanceruk.org

#LLHM2026 #CharityPartner #ActionBladderCancerUK #RunForACause #BladderCancer